𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Humour therapy in patients with late-life depression or Alzheimer's disease: a pilot study

✍ Scribed by Marc Walter; Beat Hänni; Myriam Haug; Isabelle Amrhein; Eva Krebs-Roubicek; Franz Müller-Spahn; Egemen Savaskan


Publisher
John Wiley and Sons
Year
2006
Tongue
English
Weight
124 KB
Volume
22
Category
Article
ISSN
0885-6230

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

Background

Of the disabling disorders of the elderly, depression is the most common affective disorder and Alzheimer's disease (AD) the most common neurodegenerative disorder. Pharmacological treatment strategies for these disorders are often accompanied with severe side effects. Therefore non‐pharmacological treatment strategies are of great importance. The aim of the present study was to investigate the impact of humour therapy on quality of life in patients with depression or AD.

Methods

Twenty patients with late‐life depression and 20 patients with AD were evaluated. Ten patients in each group underwent a humour therapy group (HT) once in two weeks for 60 min in addition to standard pharmacotherapy, which was given as usual to the other group as standard therapy (ST). All patients completed a psychometric test battery at admission and before discharge from the clinic.

Results

The quality of life scores improved both in HT and ST groups for depressive patients but not for patients with AD irrespective of the therapy group. Depressive patients receiving HT showed the highest quality of life after treatment. In addition, patients with depression in both therapy groups showed improvements in mood, depression score, and instrumental activities of daily living.

Conclusions

Although there was no significant effect of humour therapy comparing with standard therapy on quality of life, these findings suggest that humour therapy can provide an additional therapeutic tool. Further studies with higher frequently humour groups are required in order to investigate the impact of humour therapy in gerontopsychiatric treatment. Copyright © 2006 John Wiley & Sons, Ltd.


📜 SIMILAR VOLUMES


Skill learning in patients with moderate
✍ Alexander Rösler; Erich Seifritz; Kurt Kräuchi; David Spoerl; Ilona Brokuslaus; 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 35 KB 👁 2 views

## Abstract The authors report the effect of a 12‐day prospective, blinded dance‐learning trial in 5 patients with moderate Alzheimer's disease (AD) and 5 age‐matched depressed patients. Patients with AD showed a significant effect in procedural learning whereas depressed patients did not. These fi

The effects of music therapy on reducing
✍ Maryam Zare; Azizeh Afkham Ebrahimi; Behrooz Birashk 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 64 KB 👁 3 views

A Memory Clinic model set up to diagnose and treat Alzheimer's Disease early in the course of the illness delayed time to institutionalisation by a median of 9 months compared to controls. Treatment included pre and post diagnostic counselling, and psychosocial interventions.

A 24-week, double-blind, placebo-control
✍ Vee. P. Prasher; Adam Huxley; M. S. Haque 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 163 KB 👁 1 views

## Abstract ## Background Donepezil Hydrochloride (Aricept) is a selective anticholinesterase inhibitor developed for the treatment of Alzheimer's disease (AD). This study investigated the safety and efficacy of the drug to treat Down syndrome (DS) adults with mild to moderate AD. ## Method This

A prospective pilot study of curative-in
✍ Michael T. Milano; Alan W. Katz; Ann G. Muhs; Abraham Philip; Daniel J. Buchholz 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 139 KB 👁 1 views

## Abstract ## BACKGROUND. It is hypothesized that oligometastatic disease represents a state of potentially curable, limited metastases. Stereotactic body radiation therapy (SBRT) is an option for patients who are not amenable to or do not want resection. ## METHODS. From 2001 to 2006, 121 pati

Ciprofloxacin or metronidazole for the t
✍ Kelvin T. Thia; Uma Mahadevan; Brian G. Feagan; Cindy Wong; Alan Cockeram; Alain 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 99 KB 👁 2 views

Background: Although metronidazole and ciprofloxacin are used to treat perianal Crohn's disease (CD), no placebo-controlled trials have been performed. ## Methods: We performed a placebo-controlled pilot trial to evaluate the efficacy and safety of metronidazole and ciprofloxacin in patients with